Meet Melanoma survivor TJ Sharpe in the first installment of his new blog series on Novartis.com.

Accelerating Research to Get Answers Faster

We’re working to bring the hope of advanced medicine to more patients.

Novartis immunologist describes the excitement of discovering a promising new immuno-oncology (IO) target in the treatment of acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS).

COPD receives low attention as a women’s health issue. It’s time to change that.